BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Kostoff RN, Briggs MB, Shores DR. Treatment repurposing for inflammatory bowel disease using literature-related discovery and innovation. World J Gastroenterol 2020; 26(33): 4889-4899 [PMID: 32952337 DOI: 10.3748/wjg.v26.i33.4889] [Cited by in CrossRef: 4] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
Number Citing Articles
1 Cheerkoot-Jalim S, Khedo KK. Literature-based discovery approaches for evidence-based healthcare: a systematic review. Health Technol (Berl) 2021;:1-13. [PMID: 34722102 DOI: 10.1007/s12553-021-00605-y] [Reference Citation Analysis]
2 Kostoff RN, Briggs MB, Kanduc D, Shores DR, Kovatsi L, Drakoulis N, Porter AL, Tsatsakis A, Spandidos DA. Contributing factors common to COVID‑19 and gastrointestinal cancer. Oncol Rep 2022;47:16. [PMID: 34779496 DOI: 10.3892/or.2021.8227] [Reference Citation Analysis]
3 Retnakumar SV, Geesala R, Bretin A, Tourneur-Marsille J, Ogier-Denis E, Maretzky T, Thu Nguyen HT, Muller S. Targeting the endo-lysosomal autophagy pathway to treat inflammatory bowel diseases. J Autoimmun 2022;128:102814. [PMID: 35298976 DOI: 10.1016/j.jaut.2022.102814] [Reference Citation Analysis]
4 Kostoff RN, Kanduc D, Porter AL, Shoenfeld Y, Calina D, Briggs MB, Spandidos DA, Tsatsakis A. Vaccine- and natural infection-induced mechanisms that could modulate vaccine safety. Toxicol Rep 2020;7:1448-58. [PMID: 33110761 DOI: 10.1016/j.toxrep.2020.10.016] [Cited by in Crossref: 15] [Cited by in F6Publishing: 15] [Article Influence: 7.5] [Reference Citation Analysis]
5 da Rocha GHO, de Paula-Silva M, Broering MF, Scharf PRDS, Matsuyama LSAS, Maria-Engler SS, Farsky SHP. Pioglitazone-Mediated Attenuation of Experimental Colitis Relies on Cleaving of Annexin A1 Released by Macrophages. Front Pharmacol 2020;11:591561. [PMID: 33519451 DOI: 10.3389/fphar.2020.591561] [Reference Citation Analysis]